TRANSPLANT FAILURE side effect
What is TRANSPLANT FAILURE ?Drugs associated with TRANSPLANT FAILURE
ALDURAZYME CAMPATH CASPOFUNGIN EPOGEN FLUDARABINE PROGRAF RAPAMUNE SIROLIMUS UMBILICAL VELCADETRANSPLANT FAILURE : Campath Side Effects Report #5625708-1
Health Professional from CANADA reported CAMPATH problem on Feb 08, 2008. Female patient was diagnosed with bone marrow transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: transplant failure, . CAMPATH dosage: unknown. Patient recovered.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643566-6
FLUDARABINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643567-8
Consumer or non-health professional from NETHERLANDS reported FLUDARABINE problem on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643568-X
FLUDARABINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Feb 13, 2008. Female patient was diagnosed with prophylaxis against transplant rejection, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: AS USED: 30 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643569-1
Consumer or non-health professional from NETHERLANDS reported FLUDARABINE problem on Feb 13, 2008. Female patient was diagnosed with prophylaxis against transplant rejection, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: AS USED: 30 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643570-8
FLUDARABINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643571-X
Consumer or non-health professional from NETHERLANDS reported FLUDARABINE problem on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643572-1
FLUDARABINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5643573-3
Consumer or non-health professional from NETHERLANDS reported FLUDARABINE problem on Feb 13, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: transplant failure, . FLUDARABINE dosage: TOTAL DAILY DOSE: 120 MG/M2. During the same period patient was treated with CYCLOPHOPSHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient died.
TRANSPLANT FAILURE : Umbilical Side Effects Report #5563249-0
UMBILICAL CORD BLOOD TRANSPLANT problem was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, 53 years of age, weighting 224.9 lb, was treated with UMBILICAL CORD BLOOD TRANSPLANT. After drug was administered, patient experienced the following problems/side effects: transplant failure, . UMBILICAL CORD BLOOD TRANSPLANT dosage: unknown. During the same period patient was treated with ACYCLOVIR, AMLODIPINE, AZTREONAM, CALCIUM CARBONATE, CIPROFLAXIN, CLOTRIMAZOLE, DIPHENHYDRAMINE, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.
TRANSPLANT FAILURE : Prograf Side Effects Report #5578703-5
Physician from UKRAINE reported PROGRAF problem on Dec 11, 2007. Male patient, 30 years of age, weighting 198.4 lb, was diagnosed with immunosuppression and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: transplant failure, transplant rejection, . PROGRAF dosage: 18 MG, D, ORAL. During the same period patient was treated with CELLCEPT, METHYLPREDNISOLONE. Patient died on 12/08/2007.
TRANSPLANT FAILURE : Epogen Side Effects Report #5516852-8
EPOGEN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with renal failure chronic and was treated with EPOGEN. After drug was administered, patient experienced the following problems/side effects: transplant failure, . EPOGEN dosage: unknown. During the same period patient was treated with SENSIPAR, PREDNISONE, METOPROLOL TARTRATE, CLONIDINE, LIPITOR, MAGNESIUM OXIDE, KEPPRA, PROTONIX. Patient was hospitalized. Patient recovered.
TRANSPLANT FAILURE : Campath Side Effects Report #5635616-8
Health Professional from GERMANY reported CAMPATH problem on Feb 07, 2008. Female patient was diagnosed with t-cell depletion, prophylaxis against transplant rejection and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: infection, transplant failure, venoocclusive disease, . CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, BUSULFAN. Patient died.
TRANSPLANT FAILURE : Campath Side Effects Report #5645745-0
CAMPATH problem was reported by a Health Professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with t-cell depletion, transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: infection, transplant failure, venoocclusive disease, . CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, BUSULFAN. Patient died.
TRANSPLANT FAILURE : Prograf Side Effects Report #5592877-1
Health Professional from UNITED STATES reported PROGRAF problem on Jan 15, 2008. Male patient, weighting 282.0 lb, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of transplanted liver, transplant failure, . PROGRAF dosage: unknown. During the same period patient was treated with CELLCEPT, MYCOPHENOLATE MOFETIL. Patient recovered.
TRANSPLANT FAILURE : Rapamune Side Effects Report #5594657-X
RAPAMUNE problem was reported by a Physician from GERMANY on Jan 10, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, transplant failure, ureteric stenosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient recovered.
TRANSPLANT FAILURE : Rapamune Side Effects Report #5597007-8
Physician from GERMANY reported RAPAMUNE problem on Jan 17, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, transplant failure, ureteric stenosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient recovered.
TRANSPLANT FAILURE : Sirolimus Side Effects Report #5597126-6
SIROLIMUS problem was reported by a Physician from POLAND on Jan 09, 2008. Female patient, weighting 147.7 lb, was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: haemodialysis, transplant failure, . SIROLIMUS dosage: unknown. Patient recovered.
TRANSPLANT FAILURE : Prograf Side Effects Report #5597980-8
Physician from UKRAINE reported PROGRAF problem on Dec 21, 2007. Male patient, 30 years of age, weighting 198.4 lb, was diagnosed with immunosuppression and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: brain oedema, transplant failure, transplant rejection, . PROGRAF dosage: 18 MG, /D, ORAL. During the same period patient was treated with CELLCEPT, METHYLPREDNISOLONE. Patient died on 12/08/2007.
TRANSPLANT FAILURE : Rapamune Side Effects Report #5598721-0
RAPAMUNE problem was reported by a Physician from GERMANY on Jan 21, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, transplant failure, ureteric stenosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient recovered.
TRANSPLANT FAILURE : Caspofungin Side Effects Report #5474327-9
Consumer or non-health professional from UNITED STATES reported CASPOFUNGIN MSD problem on Sept 19, 2007. Male patient, 44 years of age, was diagnosed with fungal infection and was treated with CASPOFUNGIN MSD. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, transplant failure, . CASPOFUNGIN MSD dosage: unknown. During the same period patient was treated with CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD. Patient was hospitalized. Patient died.
TRANSPLANT FAILURE : Caspofungin Side Effects Report #5470936-1
CASPOFUNGIN MSD problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2007. Male patient, 44 years of age, was diagnosed with fungal infection and was treated with CASPOFUNGIN MSD. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, transplant failure, . CASPOFUNGIN MSD dosage: unknown. During the same period patient was treated with CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD. Patient was hospitalized. Patient died.
TRANSPLANT FAILURE : Campath Side Effects Report #5412717-0
Physician from UNITED STATES reported CAMPATH problem on Aug 02, 2007. Female patient, 20 years of age, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, transplant failure, . CAMPATH dosage: unknown. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5634990-6
FLUDARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Male patient, 17 years of age, was diagnosed with immunosuppression, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, multi-organ failure, transplant failure, . FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORIN A, METHYLPREDNISOLONE. Patient died.
TRANSPLANT FAILURE : Fludarabine Side Effects Report #5595444-9
Health Professional from UNITED KINGDOM reported FLUDARABINE PHOSPHATE problem on Jan 08, 2008. Male patient, 32 years of age, was diagnosed with bone marrow conditioning regimen and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, aplastic anaemia, transplant failure, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, CYCLOPHOSPHAMIDE. Patient recovered.
TRANSPLANT FAILURE : Prograf Side Effects Report #5599751-5
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, weighting 283.0 lb, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hepatic artery thrombosis, surgical procedure repeated, transplant failure, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient recovered.
TRANSPLANT FAILURE : Velcade Side Effects Report #5549729-2
Health Professional from UNITED STATES reported VELCADE problem on Nov 27, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, transplant failure, . VELCADE dosage: unknown. During the same period patient was treated with REVLIMID, DECADRON. Patient died on 12/15/2006.
TRANSPLANT FAILURE : Prograf Side Effects Report #5423054-2
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2007. Female patient was diagnosed with kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft thrombosis, renal failure, transplant failure, . PROGRAF dosage: 3 MG, BID. Patient recovered.
TRANSPLANT FAILURE : Aldurazyme Side Effects Report #5390724-4
Physician from NETHERLANDS reported ALDURAZYME problem on Mar 24, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, transplant failure, . ALDURAZYME dosage: unknown. Patient died.
TRANSPLANT FAILURE : Aldurazyme Side Effects Report #5390724-4
ALDURAZYME problem was reported by a Physician from NETHERLANDS on Mar 24, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, transplant failure, . ALDURAZYME dosage: unknown. Patient died.